Trial Information

Improving Cancer Pain Management Through Self-Care

Recent work from our research group demonstrated that the use of a 6-week psychoeducational
intervention, called the PRO-SELF Pain Control Program, compared to standard care, resulted
in clinically and statistically significant improvements in pain management in a sample of
oncology outpatients with bone metastasis. While the overall effects of the intervention
were significant, for approximately 70% of patients in the intervention group pain intensity
scores did not decrease by > 30% and that worst pain intensity scores remained at or above 4
at the end of the intervention. Therefore, as a logical extension of this study, we propose
a randomized clinical trial (RCT) that will test the effectiveness of two different doses of
the revised PRO-SELF Pain Control Program [i.e., PRO-SELF PLUS-HIGH and PRO-SELF PLUS-LOW]
on pain intensity and analgesic prescriptions. In addition, the sustainability of the two
doses of the intervention will be evaluated. Adult oncology outpatients with pain from bone
metastasis will be recruited, stratified by site and by whether or not they participate
alone or with a family caregiver, and randomized to one of the doses of the intervention.
The psychoeducational intervention will be conducted by specially trained oncology nurses
and will include the components of knowledge, skills training, and coaching to improve
cancer pain management. Patients in both groups will be seen in their homes over the course
of 10 weeks with phone calls conducted in between the home visits. Patients in the HIGH-DOSE
group will receive 6 visits and 10 phone calls [total time 12.3 hours]. Patients in the
LOW-DOSE group will receive 4 visits and 6 phone calls [8.0 hours]. Follow-up visits to
assess the sustainability of the intervention will be done at 2 weeks, 1 month and 3 months
after the intervention. Both quantitative and qualitative analyses will be conducted to
evaluate patient outcomes.